Joe: WHAT MAKES US DIFFERENT • AI Platform f
Post# of 36537
(Total Views: 367)
Posted On: 11/17/2020 9:12:33 PM
Joe:
WHAT MAKES US DIFFERENT
• AI Platform for biomarker discovery
• Targeted immune system modulation
• T-Cell activation for long-term immunity
• Cellular and humoral (antibody) activation for a Complete Vaccine
• Neo-antigen approaches to personalized vaccines
• Synthetic peptide manufacturing; produce mass quantities quickly with no incubation time (100 Kg = 100 million vaccines)
• NO GENE THERAPY! RNA, mRNA, DNA for immature immune systems or for sure Infants, Children, adolescents, teens or pregnant woman, period!
WHAT MAKES US DIFFERENT
• AI Platform for biomarker discovery
• Targeted immune system modulation
• T-Cell activation for long-term immunity
• Cellular and humoral (antibody) activation for a Complete Vaccine
• Neo-antigen approaches to personalized vaccines
• Synthetic peptide manufacturing; produce mass quantities quickly with no incubation time (100 Kg = 100 million vaccines)
• NO GENE THERAPY! RNA, mRNA, DNA for immature immune systems or for sure Infants, Children, adolescents, teens or pregnant woman, period!
(1)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼